Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Ian Fingerman, Ph.D.

Chief
Division of Cancer Biology (DCB)
DNA and Chromosome Aberrations Research Branch
240-276-7002
|
ian.fingerman@nih.gov

Dr. Ian Fingerman leads the branch in supporting and directing research defining the genetic and epigenetic mechanisms of tumorigenesis and mechanisms of chemical and physical carcinogenesis. He manages a portfolio of grants focusing on genetic variation in cancer and noncoding RNAs (e.g., miRNAs), as well as applications with large scale, whole "omics" approaches. 

Dr. Fingerman enjoys staying up-to-date on the latest basic science research and engaging the public through scientific outreach.  

In addition to his work for DCB, Dr. Fingerman is a member of the Data Management and Sharing Working Group - “Genomics and other Omics."

 

Research Programs

Dr. Fingerman is also involved in NIH Common Fund programs:

 

Background

Before coming to DCB, he worked as a project lead on a database for epigenetic and epigenomic data sets at the National Center for Biotechnology Information (NCBI). 

 

Education 

  • Ph.D., Molecular Biochemistry, Rutgers University

     

  • Updated:
Email